| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $267.27M | - | |
| Dir | 390.7K | $88.26M | - | |
| CEO | 152.2K | $34.38M | - | |
| VP | 72.6K | $16.41M | - | |
| CFO | 59.6K | $13.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2018 | Young Matthew P. | EVP &CFO | Sell | 700 | $158.08 | $110,657.96 | -2.1% | |
| Oct 12, 2018 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $158.46 | $31,692.00 | -0.8% | |
| Oct 1, 2018 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,300 | $167.99 | $218,387.00 | -0.5% | |
| Sep 21, 2018 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,300 | $164.36 | $213,668.00 | -0.5% | |
| Sep 17, 2018 | Young Matthew P. | EVP &CFO | Sell | 700 | $162.70 | $113,890.00 | -2.0% | |
| Sep 14, 2018 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $165.20 | $33,040.00 | -0.8% | |
| Sep 6, 2018 | Enright Patrick G74 | Director | Sale+OE | 10,130 | $168.76 | $1,709,564.68 | -14.8% | |
| Aug 15, 2018 | Young Matthew P. | EVP &CFO | Sell | 700 | $176.05 | $123,235.00 | -2.0% | |
| Aug 14, 2018 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $175.70 | $35,140.00 | -0.8% | |
| Aug 10, 2018 | Treacy Paul | SVP, Technical Operations | Sell | 1,309 | $176.61 | $231,183.41 | -7.0% |